Abrishami M, Soheilian M, Farahi A, Dowlati Y
Shaheed Beheshti University of Medical Sciences, Labbafinejad Medical Center, Ophthalmology Department and Eye Research Center, Tehran, Iran.
Eur J Dermatol. 2002 Jan-Feb;12(1):88-9.
To report successful treatment of a case of ocular leishmaniasis with combined stibogluconate and allupurinol.
A 32-year-old physician developed a non-tender reddish chalazion like lesion in his right lower lid, associated with conjunctivitis and nodular episcleritis. Biopsy of the lesion in his eyelid and conjunctiva disclosed a dense inflammatory response including histiocytes containing typical leishmania organisms.
Therapy with stibogluconate, both intralesional and intramuscular, was initiated with some improvement. However recurrence of the lesion occurred. Systemic retreatment with combined stibogluconate and allupurinol led to complete healing of the lesion.
Ocular leishmaniasis is a rare and potentially blinding disorder. Combined stibogluconate and allupurinol may be an effective therapy in such cases.
报告用葡萄糖酸锑钠和别嘌呤醇联合治疗眼部利什曼病成功的一例。
一名32岁的医生右下眼睑出现一个无痛性微红的睑板腺囊肿样病变,伴有结膜炎和结节性巩膜炎。对其眼睑和结膜病变进行活检,显示出密集的炎症反应,包括含有典型利什曼原虫的组织细胞。
开始采用病灶内和肌肉注射葡萄糖酸锑钠治疗,有一定改善。然而病变复发。用葡萄糖酸锑钠和别嘌呤醇联合进行全身再次治疗,使病变完全愈合。
眼部利什曼病是一种罕见且有潜在致盲性的疾病。葡萄糖酸锑钠和别嘌呤醇联合使用可能是此类病例的有效治疗方法。